实体瘤和转移中的CAR T细胞:为前进铺平道路
Camilla Sirini1,2, Laura De Rossi1,2, Marta Angiola Moresco1,2
1Innovative Immunotherapies Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Cancer metastasis reviews
|September 24, 2024
概括
卡尔-T细胞疗法对固体瘤有希望,但面临着挑战. 本综述探讨了改善瘤特异性,透和克服免疫抑制瘤微环境的策略,以获得更好的癌症治疗结果.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法已经彻底改变了血液癌症治疗.
- 显著的挑战限制了CAR T细胞在固体瘤中的疗效,包括毒性,瘤透不良以及免疫抑制瘤微环境.
研究的目的:
- 审查近期克服CAR T细胞治疗固体瘤障碍的进展.
- 突出提高瘤特异性的策略,解决瘤异质性,调节瘤微环境.
主要方法:
- 最近研究和临床试验的文献综述.
- 对新的CAR T细胞工程策略的分析.
- 探索改善T细胞贩运和透的方法.
- 检查对抗瘤诱导免疫抑制的方法.
主要成果:
- 目前正在进行的研究重点是改进抗原向,以减少向瘤毒性.
- 目前正在制定战略,以加强通过物理瘤屏障的CAR T细胞透.
- 调节瘤微环境对于持续的CAR T细胞活动至关重要.
结论:
- 克服目前的局限性是释放CAR T细胞治疗固体瘤潜力的关键.
- 未来的方向涉及多方面的方法,将增强的CAR T细胞设计与微环境调制相结合.
- 在固体瘤中成功应用CAR T细胞疗法需要解决特异性,贩运和免疫抑制问题.
更多相关视频
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
708
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
468
相关概念视频
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K